실시간
FierceBiotechCBER chief Prasad steps aside, deputy takes the reins as search for successor continuesFierceBiotechJ&J axes $5B CAR-T dream months after touting best-in-disease efficacyEndpoints NewsSummit slips on ivonescimab's apparent interim miss in sign of investor frustrationEndpoints NewsAmgen files update to Tavneos label as FDA escalates push to withdrawFierceBiotechChutes & Ladders—Astellas appoints new top strategist from Sanofi JapanFierceBiotechLigand tries to disembark from part of Viking pact, alleging contract breachCellBringing the genetically minimal cell to life on a computer in 4DIlluminaCanaccord cuts Illumina stock price target on competition concerns - Investing.comEndpoints NewsSeaport, Hemab price IPOs, while Avalyn soars in Nasdaq debutThermo FisherIs Thermo Fisher’s New U.S. Bioprocess Design Center Shaping a Deeper Biopharma Strategy for TMO? - simplywall.stEndpoints NewsJ&J axes pair of CAR-T therapies for lymphoma, citing evolving marketEndpoints NewsBoehringer appoints pharma veteran for corporate affairs post; BlueRock CSO heads for the exit
Thermo Fisher 2026년 4월 28일

Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg - MedTech Dive

Thermo Fisher inks $1.1B deal to sell microbiology unit to Astorg - MedTech Dive

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.